Cargando…
Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications
Triple-negative breast cancer (TNBC) accounts for ~15–20% of breast cancer (BC) and has a higher rate of early relapse and mortality compared to other subtypes. The Chemokine (C-C motif) ligand 5 (CCL5) and its signaling pathway have been linked to TNBC. We aimed to investigate the susceptibility an...
Autores principales: | Shan, Jingxuan, Chouchane, Aziz, Mokrab, Younes, Saad, Mohamad, Boujassoum, Salha, Sayaman, Rosalyn W., Ziv, Elad, Bouaouina, Noureddine, Remadi, Yasmine, Gabbouj, Sallouha, Roelands, Jessica, Ma, Xiaojing, Bedognetti, Davide, Chouchane, Lotfi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915105/ https://www.ncbi.nlm.nih.gov/pubmed/31921621 http://dx.doi.org/10.3389/fonc.2019.01328 |
Ejemplares similares
-
Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) Polymorphisms in Breast Carcinoma
por: Khedhaier, Achraf, et al.
Publicado: (2008) -
Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians
por: Shan, Jingxuan, et al.
Publicado: (2012) -
E-cadherin genetic variants predict survival outcome in breast cancer patients
por: Memni, Hager, et al.
Publicado: (2016) -
Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population
por: Mahfoudh, Wijden, et al.
Publicado: (2011) -
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
por: Mahfoudh, Wijden, et al.
Publicado: (2019)